Jerome B. Zeldis

This profile gathers the share dealings of Jerome B. Zeldis across 3 companies, led by PTC Therapeutics, Inc., Nexgel, Inc. and Soligenix, Inc. The record holds 13 filings, for trades running from 14 May 2021 to 2 January 2026.

On the market, this insider has only ever bought: 6 purchases, €98k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 share grants and 2 option exercises.

The median purchase comes to €10k. On 5 out of 6 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

On 6 January 2026 came the latest disclosure, a share grant in PTC Therapeutics, Inc. The most recent open-market purchase was published on 22 November 2024, 695 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.